385 related articles for article (PubMed ID: 7853720)
21. [Genetic association between the apolipoprotein E (ApoE) gene alleles and various forms of Alzheimer's disease].
Korovaĭtseva GI; Shcherbatykh TV; Selezneva NV; Gavrilova SI; Golimbet VE; Voskresenskaia NI; Rogaev EI
Genetika; 2001 Apr; 37(4):529-35. PubMed ID: 11421127
[TBL] [Abstract][Full Text] [Related]
22. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
[TBL] [Abstract][Full Text] [Related]
23. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
He SR; Liu DG; Wang S; Xia YJ
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
[TBL] [Abstract][Full Text] [Related]
24. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.
Strittmatter WJ; Weisgraber KH; Huang DY; Dong LM; Salvesen GS; Pericak-Vance M; Schmechel D; Saunders AM; Goldgaber D; Roses AD
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8098-102. PubMed ID: 8367470
[TBL] [Abstract][Full Text] [Related]
25. ApoE: crossroads between Alzheimer's disease and atherosclerosis.
Stojakovic T; Scharnagl H; März W
Semin Vasc Med; 2004 Aug; 4(3):279-85. PubMed ID: 15630629
[TBL] [Abstract][Full Text] [Related]
26. [The role of apolipoprotein E in the pathogenesis of Alzheimer disease].
Okuizumi K
Nihon Rinsho; 1999 Dec; 57(12):2673-7. PubMed ID: 10638195
[TBL] [Abstract][Full Text] [Related]
27. [Lipoproteins in clinical laboratory medicine].
Kuriyama M
Rinsho Byori; 1998 Dec; 46(12):1219-25. PubMed ID: 9916507
[TBL] [Abstract][Full Text] [Related]
28. Apolipoprotein E polymorphism and Alzheimer's disease.
Poirier J; Davignon J; Bouthillier D; Kogan S; Bertrand P; Gauthier S
Lancet; 1993 Sep; 342(8873):697-9. PubMed ID: 8103819
[TBL] [Abstract][Full Text] [Related]
29. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.
Vidal R; Calero M; Piccardo P; Farlow MR; Unverzagt FW; Méndez E; Jiménez-Huete A; Beavis R; Gallo G; Gomez-Tortosa E; Ghiso J; Hyman BT; Frangione B; Ghetti B
Acta Neuropathol; 2000 Jul; 100(1):1-12. PubMed ID: 10912914
[TBL] [Abstract][Full Text] [Related]
30. Fragmentation of brain apolipoprotein E (ApoE) and its relevance in Alzheimer's disease.
Amponsah AE; Feng B; Guo R; Zhang W; He J; Kong D; Dong T; Ma J; Cui H
Rev Neurosci; 2020 Aug; 31(6):589-603. PubMed ID: 32364519
[TBL] [Abstract][Full Text] [Related]
31. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
Chalmers K; Wilcock GK; Love S
Neuropathol Appl Neurobiol; 2003 Jun; 29(3):231-8. PubMed ID: 12787320
[TBL] [Abstract][Full Text] [Related]
32. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
Corder EH; Saunders AM; Strittmatter WJ; Schmechel DE; Gaskell PC; Small GW; Roses AD; Haines JL; Pericak-Vance MA
Science; 1993 Aug; 261(5123):921-3. PubMed ID: 8346443
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
Strittmatter WJ; Saunders AM; Schmechel D; Pericak-Vance M; Enghild J; Salvesen GS; Roses AD
Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1977-81. PubMed ID: 8446617
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma.
Yang DS; Smith JD; Zhou Z; Gandy SE; Martins RN
J Neurochem; 1997 Feb; 68(2):721-5. PubMed ID: 9003062
[TBL] [Abstract][Full Text] [Related]
35. Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease.
Nagy Z; Esiri MM; Jobst KA; Johnston C; Litchfield S; Sim E; Smith AD
Neuroscience; 1995 Dec; 69(3):757-61. PubMed ID: 8596645
[TBL] [Abstract][Full Text] [Related]
36. Dependence of cerebrospinal fluid Tau protein levels on apolipoprotein E4 allele frequency in patients with Alzheimer's disease.
Golombowski S; Müller-Spahn F; Romig H; Mendla K; Hock C
Neurosci Lett; 1997 Apr; 225(3):213-5. PubMed ID: 9147408
[TBL] [Abstract][Full Text] [Related]
37. Relationship between apolipoprotein E and the amyloid deposits and dystrophic neurites of Alzheimer's disease.
Dickson TC; Saunders HL; Vickers JC
Neuropathol Appl Neurobiol; 1997 Dec; 23(6):483-91. PubMed ID: 9460714
[TBL] [Abstract][Full Text] [Related]
38. Apolipoprotein E-epsilon 2 and Alzheimer's disease: genotype influences pathologic phenotype.
Lippa CF; Smith TW; Saunders AM; Hulette C; Pulaski-Salo D; Roses AD
Neurology; 1997 Feb; 48(2):515-9. PubMed ID: 9040748
[TBL] [Abstract][Full Text] [Related]
39. ApoE: the link between Alzheimer's-related glucose hypometabolism and Aβ deposition?
Patil SP; Ballard R; Sanchez S; Osborn J; Santangelo D
Med Hypotheses; 2012 Apr; 78(4):494-6. PubMed ID: 22285195
[TBL] [Abstract][Full Text] [Related]
40. Low prevalence of apolipoprotein E epsilon 4 allele in the neurofibrillary tangle predominant form of senile dementia.
Bancher C; Egensperger R; Kösel S; Jellinger K; Graeber MB
Acta Neuropathol; 1997 Nov; 94(5):403-9. PubMed ID: 9386771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]